Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philips Medical Taps Expanding PET Reimbursement Via ADAC Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Philips Medical Systems will leverage expanding Medicare coverage for positron emission tomography (PET) imaging procedures through the acquisition of PET device maker ADAC Laboratories under an agreement announced Nov. 13.

You may also be interested in...



Respironics Investors Breathing Easy After Turnaround; Stock Up 25% In Nov.

An accelerating growth rate and positive news highlighted at Respironics' Nov. 16 annual shareholder meeting breathed new life into the company's stock price. The issue closed Nov. 30 at $24.56, up $4.93, or 25.1%, for the month.

Respironics Investors Breathing Easy After Turnaround; Stock Up 25% In Nov.

An accelerating growth rate and positive news highlighted at Respironics' Nov. 16 annual shareholder meeting breathed new life into the company's stock price. The issue closed Nov. 30 at $24.56, up $4.93, or 25.1%, for the month.

GEMS High-End CT/PET System Tops Out Line Along With Positrace, Hawkeye

GE Medical Systems will complement the mid-level Positrace CT/PET scanning system, recently acquired from French manufacturer Sopha Medical Vision, with its own high-end combination system.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel